Potential Drug Target and Biomarker for SSRP1 (G6749)

Target Name: SSRP1

NCBI ID: G6749

SSRP1

Potential Drug Target and Biomarker for SSRP1

SSRP1 (Secure/Safe Social Responsibility Program 1) is a protein that is expressed in the brain and other nervous system tissues. It is a key component of the brain-gut axis, which is a communication network between the brain and the digestive system.

SSRP1 has been shown to play a role in the development and progression of several neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. It is also associated with several psychiatric disorders, including depression and anxiety.

In addition to its potential role in disease, SSRP1 has also been shown to have potential as a drug target. Studies have shown that SSRP1 can be targeted with small molecules, such as those used to treat Alzheimer's disease.

One of the reasons why SSRP1 is thought to be a potential drug target is its location in the brain. Unlike many other proteins, SSRP1 is not localized to a specific tissue or organ in the brain. Instead, it is expressed throughout the brain and other nervous system tissues. This makes it more difficult to target, but also more versatile.

Another potential reason why SSRP1 is a good candidate for a drug target is its role in the brain-gut axis. As mentioned earlier, SSRP1 is a key component of this communication network. This means that any drug that is able to disrupt the function of SSRP1 in this network could potentially have a wide range of therapeutic applications.

In addition to its potential as a drug target, SSRP1 is also of interest to researchers as a potential biomarker. Studies have shown that changes in the level of SSRP1 are associated with several neurological disorders, including Alzheimer's disease. This makes it a potential indicator of the severity and progression of these disorders.

Overall, SSRP1 is a protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in the brain-gut axis and its potential as a therapeutic intervention.

Protein Name: Structure Specific Recognition Protein 1

Functions: Component of the FACT complex, a general chromatin factor that acts to reorganize nucleosomes. The FACT complex is involved in multiple processes that require DNA as a template such as mRNA elongation, DNA replication and DNA repair. During transcription elongation the FACT complex acts as a histone chaperone that both destabilizes and restores nucleosomal structure. It facilitates the passage of RNA polymerase II and transcription by promoting the dissociation of one histone H2A-H2B dimer from the nucleosome, then subsequently promotes the reestablishment of the nucleosome following the passage of RNA polymerase II. The FACT complex is probably also involved in phosphorylation of 'Ser-392' of p53/TP53 via its association with CK2 (casein kinase II). Binds specifically to double-stranded DNA and at low levels to DNA modified by the antitumor agent cisplatin. May potentiate cisplatin-induced cell death by blocking replication and repair of modified DNA. Also acts as a transcriptional coactivator for p63/TP63

The "SSRP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SSRP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets